Harel Insurance Investments & Financial Services’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2020
Q1
Sell
-281
Closed -$54K 554
2019
Q4
$54K Buy
281
+149
+113% +$26.9K ﹤0.01% 351
2019
Q3
$22K Buy
+132
New +$21.5K ﹤0.01% 388
2018
Q4
Sell
-5,100
Closed -$971K 547
2018
Q3
$971K Sell
5,100
-4,317
-46% -$793K 0.05% 104
2018
Q2
$1.57M Sell
9,417
-180
-2% -$28.9K 0.08% 71
2018
Q1
$1.61M Buy
+9,597
New +$1.61M 0.09% 82
2017
Q1
Sell
-400
Closed -$84K 495
2016
Q4
$84K Sell
400
-294
-42% -$60.9K 0.01% 165
2016
Q3
$160K Sell
694
-41
-6% -$10K 0.02% 126
2016
Q2
$170K Buy
+735
New +$169K 0.02% 172

Other funds holding AGN

Harel Insurance Investments & Financial Services's AGN Position: Q1 2020 in Review

Harel Insurance Investments & Financial Services sold out of Allergan plc (AGN) in Q1 2020, closing a stake of 281 shares — an estimated $54K sold.

Harel Insurance Investments & Financial Services first reported a position in AGN in Q2 2016 and held it in 8 quarters. The position peaked at $1.61M in Q1 2018. 876 funds tracked by Wall St. Rank hold AGN as of Q1 2020.

  • Harel Insurance Investments & Financial Services reported no remaining Allergan plc position as of Q1 2020 after selling out during the quarter.
  • Harel Insurance Investments & Financial Services sold 281 Allergan plc shares in Q1 2020, an estimated $54K.
  • Harel Insurance Investments & Financial Services first reported a position in Allergan plc in Q2 2016 and held it in 8 quarters.
  • Harel Insurance Investments & Financial Services's Allergan plc position peaked at $1.61M in Q1 2018.
  • 876 funds tracked by Wall St. Rank held Allergan plc as of Q1 2020.

Based on Harel Insurance Investments & Financial Services's 13F filing for Q1 2020, filed 28 Apr 2020.